Exploring Undiscovered Gems in Asia This September 2025Simplywall·Sep 16, 2025 at 05:45 PM605319-0.37%688073-1.76%
Eight biopharmaceutical and CXO companies on the Sci-Tech Innovation Board gathered for a performance briefing, breaking through key technological bottlenecks became the focus of interactionZhitong·Sep 15, 2025 at 05:31 PM688089-2.40%688073-1.76%
Some shareholders of Bide Pharmaceuticals plan to reduce their holdings by no more than 1%Zhitong·Sep 12, 2025 at 06:15 AM688073-1.76%
Bide Pharmaceuticals shareholders Zhoushan Xinxie, Ningbo Landan, and their concerted parties plan to reduce their holdings by no more than 2.86% of sharesZhitong·Sep 5, 2025 at 05:29 AM688073-1.76%
A-share innovative drug concept stocks rose again, with Chemexpress, HitGen, and Medicilon increasing by over 10%, while Bide and WuXi AppTec also followed suitWallstreetcn·Aug 29, 2025 at 12:12 AM688222-3.06%688202+1.31%
The CRO index's intraday increase expanded to 3%, Medicilon hit the limit up, JOINN, Bide, Sun-Novo, and INNOSTAR followed suitZhitong·Jul 8, 2025 at 10:04 PM603127-1.16%06127-1.10%
The CRO sector rose, with JOINN up 8.94%, GEMPHARMATECH up 7.3%, Bide up 6.7%, and TIGERMED, Chemexpress, and Sun-Novo all rising over 5%Zhitong·Jun 29, 2025 at 10:15 PM603127-1.16%06127-1.10%
Midday Break | The three major indices of A-shares all fell36Kr·Jun 12, 2025 at 10:32 PM300703-1.25%002343-0.96%
Overview of A-share dividends and stock distributions: 71 stocks have their equity registration todayZhitong·Jun 5, 2025 at 07:42 PM603590-1.12%300963+0.08%
CRO concept stocks continue to rise, Bide up 7.6%, LIANHE TECHNOLOGY up 5.92%, Pharmaron up 4.92%, Medpace, WuXi AppTec, and PHARMABLOCK up over 3%Zhitong·May 28, 2025 at 08:51 PM300725-0.04%688073-1.76%
Bide Pharmaceuticals: Appointed Wang Xuan as the company's board secretaryZhitong·May 19, 2025 at 03:24 AM688073-1.76%
Bide Pharmaceuticals establishes a biotechnology subsidiaryZhitong·May 18, 2025 at 09:20 PM688073-1.76%
Bide Pharmaceuticals has repurchased 2% of its shares at a cost of 82.031 million yuanZhitong·May 16, 2025 at 02:40 AM688073-1.76%
Bide Pharmaceuticals released its 2024 annual performance, with a net profit attributable to the parent company of 117 million yuan, a year-on-year increase of 7.17%Zhitong·Apr 23, 2025 at 09:42 AM688073-1.76%
Bide Pharmaceuticals released its first-quarter performance, with a net profit attributable to the parent company of 30.69 million yuan, a year-on-year increase of 17.71%Zhitong·Apr 23, 2025 at 09:38 AM688073-1.76%
